A traditional Chinese medicine preparation for regulating hyperlipidemia

Abstract

The invention belongs to the technical field of traditional Chinese medicine, and relates to a traditional Chinese medicine preparation for regulating hyperlipidemia, which is composed of silver rattan tea, crucian jujube, notoginseng flower, hawthorn, kudzu root, turmeric, Yuanhu, astragalus, aconite, puhuang and radix japonicus 7-, Danshen, Maodongqing, white peony, the present invention is based on the secret recipe handed down from the ancestors, combined with the summary of his many years of clinical experience, obtained through repeated experiments, so the medicine has a unique effect on intractable hyperlipidemia. It adopts multi-drug scientific compatibility and comprehensive treatment so that the active ingredients of the drug can quickly enter the blood circulation, lower blood cholesterol, block thrombosis, expand coronary arteries, increase blood flow, improve the tolerance of myocardial ischemia, improve Cerebral infarction, repair damaged brain nerves, and quickly recover from hyperlipidemia. The medicine of the invention has unique curative effects on hypertension, hyperlipidemia, diabetes, brain atrophy, cerebral thrombosis, coronary heart disease, cerebral arteriosclerosis and stroke sequelae. Moreover, it has the advantages of quick effect, short course of treatment, high cure rate and low cost.

Description

technical field [0001] The invention relates to a traditional Chinese medicine preparation, in particular to a traditional Chinese medicine preparation for regulating hyperlipidemia prepared from Chinese herbal medicines. Background technique [0002] Hyperlipidemia refers to excessive blood lipid levels, which can directly cause some diseases that seriously endanger human health, such as atherosclerosis, coronary heart disease, pancreatitis, etc. The clinical manifestations of hyperlipidemia are mainly xanthoma caused by lipid deposition in the dermis and arteriosclerosis caused by lipid deposition in the vascular endothelium. [0003] According to China's survey statistics in recent years, the prevalence of coronary heart disease in China has reached more than 60%, and about 50% of them have hyperlipidemia. Among patients with myocardial infarction, hypertriglyceridemia has reached about 80%, and hyperlipidemia is the main cause of cerebrovascular disease. [0004] At p...

AI Technical Summary

Problems solved by technology

[0004] At present, there are two kinds of treatment methods for hyperlipidemia at home and abroad, one is diet therapy, while restrictive diet therapy reduces hyperlipidemia, and at the same time causes a certain composition and degree of imbalance to the normal nutritional source of the human body, and achieves the purpose of curative effect time is long

However, Western medicine lipid-lowering therapy has side effects of varying degrees, causing intestinal adverse reactions, and cannot be cured. After stopping the drug, the cholesterol, triglycerides and other indicators increased significantly

Some drugs still have the disadvantage that the effect of the drug cannot be sustained, and rebound after stopping the drug, so it must be taken continuously for a long time

These problems affect the efficacy of drugs and increase the financial burden on patients